Early observations and pilot data that first suggested a new direction
Fast-track perioperative care brought multiple interventions into a shared recovery pathway. The supplied review examined pain control, approaches to reducing the surgical stress response, minimally invasive access and multimodal care programs. It reported that newer perioperative approaches had reduced morbidity and mortality and emphasized coordination among anesthesiologists, surgeons, nurses and physical therapists. The central principle was to improve recovery through combined care rather than relying on a single intervention. This provided a framework for testing enhanced-recovery pathways in clinical studies.
Landmark RCTs and pivotal trials that established the evidence base
LAFA compared laparoscopy and open colectomy within fast-track or standard care. Total hospital stay was shortest with laparoscopic fast-track care; regression analysis identified laparoscopy as the independent predictor of shorter stay and lower morbidity. EnROL compared laparoscopic with open colorectal surgery within an enhanced-recovery program. Its primary physical-fatigue outcome at 1 month did not differ significantly; median stay was 5 versus 7 days (p=0.033). A meta-analysis of open colorectal surgery found shorter stay with ERAS (weighted mean difference -2.55) and fewer complications (RR 0.53), without significant differences in readmission or mortality.
Follow-up studies, subgroup analyses, and real-world validation
RELIEF tested restrictive versus liberal perioperative fluid regimens in major abdominal surgery. Disability-free survival at 1 year was 81.9% versus 82.3% (p=0.61), while acute kidney injury occurred in 8.6% versus 5.0% (p<0.001). The restrictive strategy did not improve the primary outcome and increased kidney injury. Separately, a prospective colorectal cohort found that improved ERAS adherence was associated with fewer complications (OR 0.73; 95% CI 0.55–0.98). Adverse postoperative outcomes also declined across increasing adherence categories. This association supports evaluating implementation as well as individual pathway components.
Integration into clinical practice guidelines and recommendations
The 2018 ERAS Society colorectal guideline uses GRADE and gives element-specific recommendations. It strongly recommends routine preoperative counselling, avoiding prolonged fasting, preoperative carbohydrate drinks, oral food and nutritional supplements from the day of surgery for most patients, and early mobilisation. Mechanical bowel preparation alone should not be routine in colonic surgery but may be used in rectal surgery (strong); combined mechanical preparation and oral antibiotics has a weak recommendation. Short-acting anaesthetics and procedure-specific opioid-sparing multimodal analgesia are included. Goal-directed fluids are strongly recommended for high-risk patients or large intravascular losses, with a weak recommendation in low-risk patients. Strengths vary by element.
ERAS Society Colorectal Guidelines 2018
Strong recommendations include routine counselling, avoiding prolonged fasting, preoperative carbohydrate drinks, oral food/nutritional supplements from the day of surgery for most patients, and early mobilisation. Do not routinely use mechanical bowel preparation alone in colonic surgery; it may be used in rectal surgery (strong). Combined mechanical preparation and oral antibiotics: weak. Goal-directed fluids: strong for high risk or large intravascular losses, weak for low risk.
ERAS Society colorectal recommendations 2018
Use procedure-specific opioid-sparing multimodal analgesia, encourage early mobilisation, and tailor goal-directed fluids to risk: strong for high-risk patients or large intravascular losses, weak for low-risk patients.
ERAS Society anaesthesia consensus for gastrointestinal surgery
Use procedure-specific opioid-sparing multimodal analgesia; prevent hypothermia and tailor PONV prophylaxis to risk. Tailor fluid therapy to patient and surgical factors, especially high-risk or large-loss procedures.
Now
Current standard of care and ongoing research directions
A prospective colorectal-cancer cohort studied adherence before and after reinforcement of an ERAS protocol in 953 consecutive patients at one Stockholm hospital. Preoperative/perioperative adherence rose from 43.3% to 70.6%, alongside fewer postoperative complications (OR 0.73; 95% CI 0.55–0.98) and symptoms (OR 0.53; 95% CI 0.40–0.70). Higher adherence categories were associated with fewer adverse outcomes. This is an observational association, not a randomized estimate of the contribution of each element. Clinical implementation should assess both pathway adherence and patient outcomes.
The 2018 colorectal guideline groups care into preadmission, preoperative, intraoperative and postoperative phases. It recommends routine preoperative counselling; solids until 6 hours and clear fluids until 2 hours before anaesthesia in elective patients without delayed gastric emptying. The guideline excludes carbohydrate drinks in patients with gastrointestinal motility disorders. Avoid routine mechanical bowel preparation alone in colonic surgery; it may be used in rectal surgery (strong). Combined mechanical preparation and oral antibiotics has a weak recommendation. Intraoperative care includes short-acting anaesthetics, minimally invasive surgery where appropriate, normothermia and opioid-sparing multimodal analgesia. Tailor goal-directed fluids to risk: strong for high risk or large intravascular losses, weak for low risk. Offer food and oral supplements from the day of surgery to most patients and encourage early mobilisation (strong). Avoid routine pelvic/peritoneal drains; remove urinary catheters on day 1 at low retention risk, allowing up to 3 days at moderate/high risk (strong).
Does ERAS increase readmission rates?+
In a meta-analysis of randomized trials in major elective open colorectal surgery, ERAS reduced hospital stay and complication rates. Readmission and mortality rates did not differ significantly from conventional care. These findings apply to the studied pathways and population; they do not establish that every accelerated-discharge program has the same outcomes.
What is the anaesthesiologist's role in ERAS?+
ERAS’s 2016 GI anaesthesia consensus recommends risk assessment, warming, risk-based PONV prevention, avoiding long-acting anxiolytics/opioids and procedure-specific regional/nonopioid analgesia. Paracetamol/NSAIDs need contraindication checks. Ketamine/gabapentinoids may spare opioids but cause dizziness/sedation; most analgesic evidence was outside ERAS. Goal-directed fluids especially suit high risk/large losses.
Should fluid therapy be restrictive or liberal within ERAS?+
RELIEF found no improvement in 1-year disability-free survival with restrictive fluids and more AKI (8.6% vs 5.0%). The 2016 ERAS anaesthesia consensus describes goal-directed fluids using stroke-volume changes, avoiding fluid excess and hypoperfusion. It favors this especially in high-risk or large-loss surgery; benefit in low-risk ERAS patients was not established.